TGM2 and prostate neoplasm: Collectively, these findings demonstrate that TGM2 expression correlates with HIF1A signaling in mice and human prostatic tumors, has potential prognostic value in predicting relapse in patients with PCa, and may thus be used to guide their clinical management.